CStone Announces FDA Clearance of IND Application for Its Novel Trispecific Antibody CS2009 (PD-1/VEGF/CTLA-4) to Advance into Phase II Clinical Trial Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4888475_CN88475_0